Impact of a Predictive Score of Bowel Preparation Quality in Clinical Practice

• Status: Completed
• Trial end date: 2019-10-30
• Target enrollment: 0
• Participant gender: All

Summary

This is a single center randomized controlled trial to compare the colon cleansing quality determined by the Boston Bowel Preparation Scale achieved by two strategies in patients with high risk of poor colon cleansing defined as those patients with a score> 1.225 following a predictive score previously published: one group will receive an intensified split-dose 4 L polyethylene glycol solution (PEG) plus bisacodyl and 3 days of fiber-free diet and the other group a split-dose 2 L PEG solution with ascorbic plus bisacodyl and 1 day of fiber-free diet.

Patients with a score ≤ 1.225 will receive a split-dose 2 L PEG solution with ascorbic plus bisacodyl and 1 day of fiber-free diet.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Universitario de Canarias
• Treatments: Ascorbic Acid

Criteria

Inclusion Criteria:

• Age ≥ 18 years

• Outpatient colonoscopy

• Willing to participate (informed consent signed).

Exclusion Criteria:

• Intestinal perforation

• Poorly controlled arterial hypertension (HTAS> 180 HTAD> 100)

• Congestive heart failure

• NYHA III-IV

• Acute hepatic failure

• End-stage renal disease (creatinine <15 ml / min dialysis or pre-dialysis)

• Pregnancy or breastfeeding

• Known hypersensitivity reaction to drug components

• Phenylketonuria or Glucose-6-phosphate dehydrogenase deficiency

• Dementia with difficulty in intake of Preparation

• Past history of poor bowel preparation colonic cleanliness

• Inability to follow the instructions